Lau B - Search Results

1

Rapid declines in total lymphocyte counts and hemoglobin concentration prior to AIDS among HIV-1-infected men.

Lau B, Gange SJ, Phair JP, Riddler SA, Detels R, Margolick JB. Lau B, et al. AIDS. 2003 Sep 26;17(14):2035-44. doi: 10.1097/00002030-200309260-00004. AIDS. 2003. PMID: 14502006

2

Rapid declines in total lymphocyte count and hemoglobin in HIV infection begin at CD4 lymphocyte counts that justify antiretroviral therapy.

Gange SJ, Lau B, Phair J, Riddler SA, Detels R, Margolick JB. Gange SJ, et al. Among authors: lau b. AIDS. 2003 Jan 3;17(1):119-21. doi: 10.1097/00002030-200301030-00016. AIDS. 2003. PMID: 12478077 No abstract available.

3

Methods for the analysis of continuous biomarker assay data with increased sensitivity.

Lau B, Gange SJ. Lau B, et al. Epidemiology. 2004 Nov;15(6):724-32. doi: 10.1097/01.ede.0000142154.86749.e4. Epidemiology. 2004. PMID: 15475722

4

Use of total lymphocyte count and hemoglobin concentration for monitoring progression of HIV infection.

Lau B, Gange SJ, Phair JP, Riddler SA, Detels R, Margolick JB. Lau B, et al. J Acquir Immune Defic Syndr. 2005 Aug 15;39(5):620-5. J Acquir Immune Defic Syndr. 2005. PMID: 16044017

5

C-reactive protein is a marker for human immunodeficiency virus disease progression.

Lau B, Sharrett AR, Kingsley LA, Post W, Palella FJ, Visscher B, Gange SJ. Lau B, et al. Arch Intern Med. 2006 Jan 9;166(1):64-70. doi: 10.1001/archinte.166.1.64. Arch Intern Med. 2006. PMID: 16401812

6

Risk of non-AIDS-related mortality may exceed risk of AIDS-related mortality among individuals enrolling into care with CD4+ counts greater than 200 cells/mm3.

Lau B, Gange SJ, Moore RD. Lau B, et al. J Acquir Immune Defic Syndr. 2007 Feb 1;44(2):179-87. doi: 10.1097/01.qai.0000247229.68246.c5. J Acquir Immune Defic Syndr. 2007. PMID: 17075385

7

Interval and clinical cohort studies: epidemiological issues.

Lau B, Gange SJ, Moore RD. Lau B, et al. AIDS Res Hum Retroviruses. 2007 Jun;23(6):769-76. doi: 10.1089/aid.2006.0171. AIDS Res Hum Retroviruses. 2007. PMID: 17604539

8

Evaluating competing adverse and beneficial outcomes using a mixture model.

Lau B, Cole SR, Moore RD, Gange SJ. Lau B, et al. Stat Med. 2008 Sep 20;27(21):4313-27. doi: 10.1002/sim.3293. Stat Med. 2008. PMID: 18416435 Free PMC article.

9

Effect of early versus deferred antiretroviral therapy for HIV on survival.

Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, Hogg RS, Deeks SG, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Martin JN, Klein MB, Jacobson LP, Rodriguez B, Sterling TR, Kirk GD, Napravnik S, Rachlis AR, Calzavara LM, Horberg MA, Silverberg MJ, Gebo KA, Goedert JJ, Benson CA, Collier AC, Van Rompaey SE, Crane HM, McKaig RG, Lau B, Freeman AM, Moore RD; NA-ACCORD Investigators. Kitahata MM, et al. Among authors: lau b. N Engl J Med. 2009 Apr 30;360(18):1815-26. doi: 10.1056/NEJMoa0807252. Epub 2009 Apr 1. N Engl J Med. 2009. PMID: 19339714 Free PMC article.

10

Evaluation of human immunodeficiency virus biomarkers: inferences from interval and clinical cohort studies.

Lau B, Gange SJ, Kirk GD, Moore RD. Lau B, et al. Epidemiology. 2009 Sep;20(5):664-72. doi: 10.1097/EDE.0b013e3181a71519. Epidemiology. 2009. PMID: 19478669 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,277 results

Search Page

Filters